Overview

Post-marketing Surveillance of Bixalomer in Patients With Pre-dialysis Chronic Kidney Disease

Status:
Completed
Trial end date:
2018-12-31
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess the long-term safety and efficacy of bixalomer under post-marketed setting.
Details
Lead Sponsor:
Astellas Pharma Inc